In this Editorial, Rhian Touyz, Editor-in-Chief of Clinical Science, reflects on how the journal has grown, highlights the journal’s multidisciplinary scope and shares ambitions on exciting new aims and initiatives for the journal as we look forward.
Published by Portland Press, on behalf of the Biochemical Society, Clinical Science is a peer-reviewed journal offering the option to publish open access (OA). As the UK’s largest learned society, the Biochemical Society is at the forefront of promoting the advancement of molecular bioscience and all publishing profits are returned to the Society to support this mission.
The mission of Clinical Science is to publish the highest quality research that focuses on molecular mechanisms of human disease. It is a home for showcasing comprehensive studies that use a multidisciplinary approach, including experimental models of human disease and clinical perspectives, to advance human health. The breadth of the Clinical Science scope is supported and advanced by its international Editorial Board, which provides an essential link with research communities around the world. Our panel of expert Associate Editors is responsible for assessing submissions on a broad spectrum of molecular biosciences and selecting those that deliver the translational links to disease mechanisms. Check out a selection of our published content highlighting the interdisciplinary scope of the journal [1–7].
Submissions to Clinical Science have grown by 30% over the previous 2 years and we are delighted to be supported by international authorship from across the globe including Europe, North and South America, Asia and Australia. Our international authorship has contributed innovative translational research as well as compelling reviews that have led to the success of Clinical Science in being ranked in the top quartile in the Medicine (Research & Experimental) category and achieving an Impact Factor of 5.237 (2018 Journal Citation Reports, Web of Science Group, 2019). In 2019, Clinical Science had over 650K total article views and our average timeline from acceptance to publication was 14 days.
The accomplishments of Clinical Science have inspired the leadership of the journal to look ahead and implement some exciting new initiatives including insights from our own Editorial Board on the future directions of subject areas including, but not limited to; the Cardiovascular and Respiratory System, Vascular Biology, Genome Medicine, Infection and Immunity, Oncology, and the Gastrointestinal Tract and Liver. Look out for our new cardiovascular oncology themed collection, which will be guest edited by myself and Clinical Senior Lecturer, Ninian Lang from the University of Glasgow. Check out some of the published content in our themed collection [8,9] on adipose biology, cardiovascular and cardiometabolic disease, guest edited by Dr Ahmed El-Yazbi (American University of Beirut) and Professor Gavin Oudit (University of Alberta).
In addition to publishing the best science linking discovery science to clinical impact, Clinical Science supports the next generation of biomedical scientists through research awards, given at numerous scientific meetings, including Experimental Biology, European Council on Cardiovascular Research, and Council on Hypertension (AHA).
The Biochemical Society and Portland Press launched their new Read & Publish pilots in alignment with their innovative approach to supporting the transition toward OA in January 2020, providing an APC (article publishing charge)-free route for publishing OA in Clinical Science. For more information on the Read & Publish pilots or to check if your institution is already signed up, you can read more here.
Why not consider submitting your next research paper to Clinical Science? Please do not hesitate to contact any member of the Editorial Board or the Editorial Office (firstname.lastname@example.org) if you have any pre-submission queries.
Together with the Associate Editors and Editorial Board of Clinical Science, we look forward to welcoming you to our readership and to receiving your best research for consideration.
The author of this Editorial, Rhian M. Touyz, is the Editor-in-Chief of Clinical Science. The author declares that there are no other competing interests associated with the manuscript.